1. Home
  2. PGEN

PGEN

Precigen Inc.

Logo Precigen Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Founded: 1998 Country:
United States
United States
Employees: N/A City: GERMANTOWN
Market Cap: 353.5M IPO Year: N/A
Target Price: $10.00 AVG Volume (30 days): 1.0M
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.39 EPS Growth: N/A
52 Week Low/High: $0.84 - $1.88 Next Earning Date: 05-08-2024
Revenue: $6,225,000 Revenue Growth: -76.87%
Revenue Growth (this year): -9.56% Revenue Growth (next year): 596.55%

Share on Social Networks: